Name
Synthesis of novel bi-metallic doped LaNiO3 as an advanced hybrid oxygen carrier-sorbent for chemical looping carbon capture applications
Date & Time
Wednesday, October 2, 2024, 9:00 AM - 9:20 AM
Description

In this study, a novel bi-metallic doped LaNiO3 perovskite was synthesized via sol-gel technique, followed by doping with varying compositions of metals by wet impregnation method. This tailored perovskite material was specifically designed for the application within sorption-enhanced chemical looping (SE-CL) technique. The synthesized perovskite was physically mixed with silicalite-1 zeolite, with mass ratio of 9:1 to enhance its reactivity and cyclic stability. The surface area of as-prepared oxy sorbent was analyzed using BET while material’s morphology was assessed using SEM. Additionally, the crystalline phase pattern and metallic composition were investigated through XRD and XPS respectively. SEM and XRD analyses revealed the presence of perovskite and porous structure of oxygen carrier, while XPS spectra indicated the presence of lattice oxygen. To assess redox properties of catalyst and its CO2 capacity, TGA was used. The metallic doped perovskite material was subjected to 20 consecutive reduction (using CH4) and oxidation (using air) cycles in TGA over a range of temperatures (700-950 °C) to evaluate its stability, with each cycle being separated by nitrogen purge. The material demonstrated excellent stability over multiple cycles and exhibited its highest oxygen transfer capacity at 12.16 mmol/g under operating conditions. The novel composite material was evaluated in a packed bed reactor under similar conditions to that of TGA for decarbonization of blast furnace gases. Remarkably, a reduction in CO2 concentration up to 97% was achieved. Furthermore, material exhibited consistent and efficient performance over 20 cycles, indicating its potential as promising oxy sorbent to scale up SE-CL technique.

Location Name
Max Bell 156
Full Address
Banff Centre for Arts and Creativity
107 Tunnel Mountain Dr
Banff AB T1L 1H5
Canada
Session Type
Oral Presentation
Abstract ID
1053